FOLH1 and prostate neoplasm: CLSM also showed the same trend (Figure 4B); the PSMA-targeted groups presented as bright red light in cells, while the light was weak for untargeted nanoparticles, indicating that nanoparticles could aggregate into prostate tumor cells actively and efficiently through PSMA targeting modification to achieve their functions.